Better understanding of the different mutations that drive GIST is leading to new paradigms of tailored treatment that break many norms of chemotherapy, especially in management of progression.
Related Articles
Cover Story
Jean-Yves Blay: integrating translational and clinical research
Grandround
Managing common toxicities with new tyrosine kinase inhibitors
Senza categoria